rs16043
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001127222.2(CACNA1A):c.5732-6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,610,218 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001127222.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.5732-6T>C | splice_region_variant, intron_variant | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.5732-6T>C | splice_region_variant, intron_variant | 1 | NM_001127222.2 | ENSP00000353362.5 | ||||
CACNA1A | ENST00000638029.1 | c.5750-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000489829.1 | |||||
CACNA1A | ENST00000573710.7 | c.5738-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000460092.3 | |||||
CACNA1A | ENST00000635727.1 | c.5735-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490001.1 | |||||
CACNA1A | ENST00000637769.1 | c.5735-6T>C | splice_region_variant, intron_variant | 1 | ENSP00000489778.1 | |||||
CACNA1A | ENST00000636012.1 | c.5735-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490223.1 | |||||
CACNA1A | ENST00000637736.1 | c.5594-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000489861.1 | |||||
CACNA1A | ENST00000636389.1 | c.5735-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000489992.1 | |||||
CACNA1A | ENST00000637432.1 | c.5750-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490617.1 | |||||
CACNA1A | ENST00000636549.1 | c.5741-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490578.1 | |||||
CACNA1A | ENST00000637927.1 | c.5738-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000489715.1 | |||||
CACNA1A | ENST00000635895.1 | c.5735-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490323.1 | |||||
CACNA1A | ENST00000638009.2 | c.5735-6T>C | splice_region_variant, intron_variant | 1 | ENSP00000489913.1 | |||||
CACNA1A | ENST00000637276.1 | c.5735-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000489777.1 | |||||
CACNA1A | ENST00000636768.1 | n.*34-6T>C | splice_region_variant, intron_variant | 5 | ENSP00000490190.2 |
Frequencies
GnomAD3 genomes AF: 0.000874 AC: 133AN: 152184Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00236 AC: 580AN: 245390Hom.: 13 AF XY: 0.00312 AC XY: 415AN XY: 133178
GnomAD4 exome AF: 0.00116 AC: 1695AN: 1457916Hom.: 24 Cov.: 30 AF XY: 0.00163 AC XY: 1181AN XY: 725176
GnomAD4 genome AF: 0.000867 AC: 132AN: 152302Hom.: 2 Cov.: 32 AF XY: 0.00113 AC XY: 84AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 09, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 27, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 05, 2024 | - - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
CACNA1A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at